- Home
- CEE vs VNRX Comparison
CEE vs VNRX Comparison
Compare CEE & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CEE | VNRX |
|---|---|---|
| Founded | 1990 | N/A |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 101.1M | 38.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CEE | VNRX |
|---|---|---|
| Price | $17.05 | $0.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $3.17 |
| AVG Volume (30 Days) | 22.0K | ★ 2.8M |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | ★ 3.86% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,472,007.00 |
| Revenue This Year | N/A | $55.33 |
| Revenue Next Year | N/A | $493.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 14.48 |
| 52 Week Low | $7.80 | $0.23 |
| 52 Week High | $10.32 | $0.94 |
Technical Indicators
Market Signals| Indicator | CEE | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 61.95 | 36.72 |
| Support Level | $16.20 | $0.23 |
| Resistance Level | $18.10 | $0.31 |
| Average True Range (ATR) | 0.43 | 0.03 |
| MACD | 0.05 | 0.00 |
| Stochastic Oscillator | 50.26 | 32.56 |
Price Performance
Historical ComparisonAbout CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.